ATE77557T1 - Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. - Google Patents
Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung.Info
- Publication number
- ATE77557T1 ATE77557T1 AT88309826T AT88309826T ATE77557T1 AT E77557 T1 ATE77557 T1 AT E77557T1 AT 88309826 T AT88309826 T AT 88309826T AT 88309826 T AT88309826 T AT 88309826T AT E77557 T1 ATE77557 T1 AT E77557T1
- Authority
- AT
- Austria
- Prior art keywords
- increase
- levels
- composition
- rate
- physical performance
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Immunology (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Dermatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Physical Or Chemical Processes And Apparatus (AREA)
- Cosmetics (AREA)
- Saccharide Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US07/139,288 US4871718A (en) | 1987-12-29 | 1987-12-29 | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
EP88309826A EP0324227B1 (de) | 1987-12-29 | 1988-10-19 | Zusammensetzung zur Erhöhung der Intrazell-ATP-Spiegel und des physischen Leistungsniveaus und zur Erhöhung der Geschwindigkeit von Wundenheilung |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE77557T1 true ATE77557T1 (de) | 1992-07-15 |
Family
ID=22485942
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT88309826T ATE77557T1 (de) | 1987-12-29 | 1988-10-19 | Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. |
Country Status (12)
Country | Link |
---|---|
US (2) | US4871718A (de) |
EP (1) | EP0324227B1 (de) |
JP (1) | JPH01175939A (de) |
AT (1) | ATE77557T1 (de) |
AU (1) | AU600139B2 (de) |
CA (1) | CA1325593C (de) |
DE (2) | DE3872372T2 (de) |
DK (1) | DK726088A (de) |
ES (1) | ES2045141T3 (de) |
GR (1) | GR900300016T1 (de) |
IE (1) | IE62263B1 (de) |
NZ (1) | NZ225106A (de) |
Families Citing this family (89)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4871718A (en) * | 1987-12-29 | 1989-10-03 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
JPH01308232A (ja) * | 1988-06-03 | 1989-12-12 | Takeda Chem Ind Ltd | 固型医薬およびその製造法 |
IT1247125B (it) * | 1991-03-01 | 1994-12-12 | Depha Team Srl | Composizioni dietetiche o farmaceutiche per il ripristino del contenuto cellulare degli adenin nucleotidi nel muscolo scheletrico e cardiaco. |
US5195940A (en) * | 1991-06-20 | 1993-03-23 | Iatromed, Inc. | Method for increased production of growth factor in living tissue using an applied fluctuating magnetic field |
CA2078019C (en) * | 1991-09-13 | 2002-08-27 | Siegbert Heinrich Bissbort | Substance or composition and uses thereof |
GB9218449D0 (en) | 1992-08-29 | 1992-10-14 | Boots Co Plc | Therapeutic agents |
GB9215746D0 (en) * | 1992-07-24 | 1992-09-09 | Hultman Eric | A method of increasing creatine supply depot |
ATE332127T1 (de) * | 1994-11-08 | 2006-07-15 | Avicena Group Inc | Verwendung von kreatin oder kreatinanologen zur behandlung von huntington chorea, morbus parkinson und amyotrophen lateralsklerose |
AU4704596A (en) * | 1995-01-20 | 1996-08-07 | Francis J. Carniglia | Diet compositions to treat ascites in domestic animals |
US6596701B1 (en) * | 1995-04-25 | 2003-07-22 | Mediquest Therapeutics, Inc. | S-adenosyl methionine regulation of metabolic pathways and its use in diagnosis and therapy |
US5827874A (en) * | 1995-05-05 | 1998-10-27 | Meyer; Hans | Methods of treating pain and inflammation with proline |
US5571518A (en) * | 1995-10-30 | 1996-11-05 | Chesebrough-Pond's Usa Co., Division Of Conopco, Inc. | Cosmetic compositions containing tricholine citrate |
US5733884A (en) | 1995-11-07 | 1998-03-31 | Nestec Ltd. | Enteral formulation designed for optimized wound healing |
US8128955B2 (en) * | 1996-05-31 | 2012-03-06 | The Original Creatine Patent Company | Food compositions containing creatine |
US7150880B2 (en) * | 1996-05-31 | 2006-12-19 | The Original Creatine Patent Co. Ltd. | Compositions containing creatine and creatinine and a methyl xanthine |
US6013273A (en) * | 1997-01-27 | 2000-01-11 | Novartis Nutrition Ag | Treatment of endotoxic shock |
US6207713B1 (en) * | 1997-09-17 | 2001-03-27 | Eric T. Fossel | Topical and oral delivery of arginine to cause beneficial effects |
US7914814B2 (en) * | 1997-09-17 | 2011-03-29 | Strategic Science & Technologies, Llc | Topical delivery of arginine of cause beneficial effects |
US7629384B2 (en) * | 1997-09-17 | 2009-12-08 | Strategic Science & Technologies, Llc | Topical delivery of L-arginine to cause beneficial effects |
US6159942A (en) * | 1998-06-19 | 2000-12-12 | Bioenergy, Inc. | Compositions for increasing energy in vivo |
US6218366B1 (en) * | 1998-06-19 | 2001-04-17 | Bioenergy, Inc. | Method for raising the hypoxic threshold |
GB9814039D0 (en) * | 1998-06-29 | 1998-08-26 | Univ London | Materials and methods relating to the prevention or treatment of ischaemia-reperfusion injury |
FR2782270B1 (fr) * | 1998-08-12 | 2001-06-22 | Michel Seman | Adenosine et nucleotides adenyliques par voie orale pour l'amelioration du travail musculaire |
US6616942B1 (en) | 1999-03-29 | 2003-09-09 | Soft Gel Technologies, Inc. | Coenzyme Q10 formulation and process methodology for soft gel capsules manufacturing |
US20020119933A1 (en) * | 2000-07-28 | 2002-08-29 | Butler Terri L. | Compositions and methods for improving cardiovascular function |
US6429198B1 (en) | 1999-04-12 | 2002-08-06 | Bioenergy Inc. | Compositions for increasing athletic performance in mammals |
US6534480B2 (en) | 1999-06-17 | 2003-03-18 | Bioenergy Inc. | Compositions for increasing energy in vivo |
US6242491B1 (en) * | 1999-06-25 | 2001-06-05 | Rima Kaddurah-Daouk | Use of creatine or creatine compounds for skin preservation |
US6562869B1 (en) | 1999-09-23 | 2003-05-13 | Juvenon, Inc. | Nutritional supplement for increased energy and stamina |
WO2001021208A1 (en) | 1999-09-23 | 2001-03-29 | Juvenon Corporation | Nutritional supplement for increased energy and stamina |
US6339716B1 (en) | 1999-09-24 | 2002-01-15 | Bioenergy Inc. | Method for determining viability of a myocardial segment |
US6159943A (en) * | 1999-09-24 | 2000-12-12 | Bioenergy, Inc. | Use of ribose to prevent cramping and soreness in muscles |
US6703370B1 (en) | 1999-10-27 | 2004-03-09 | Bioenergy, Inc. | Use of ribose to treat fibromyalgia |
WO2001032168A1 (en) | 1999-11-03 | 2001-05-10 | Juvenon, Inc. | Method of treating benign forgetfulness |
CA2397707A1 (en) | 2000-01-07 | 2001-07-19 | Susan S. Percival | Compositions for enhancing the immune response |
KR100338491B1 (ko) * | 2000-03-30 | 2002-05-30 | 채수경 | 인중합체로 된 흉터 억제 및 상처 회복 촉진제 |
US7713546B1 (en) * | 2001-04-03 | 2010-05-11 | Soft Gel Technologies, Inc. | Corosolic acid formulation and its application for weight-loss management and blood sugar balance |
US6553254B1 (en) * | 2000-04-07 | 2003-04-22 | Keith E. Kenyon | Combination of non-living-source physical energy and living-source chemical energy to maximize the salvage of ATP |
US6420342B1 (en) * | 2000-05-08 | 2002-07-16 | N.V. Nutricia | Nutritional preparation comprising ribose and medical use thereof |
ES2275703T3 (es) * | 2000-07-28 | 2007-06-16 | Bioenergy Inc. | Composiciones y metodos para mejorar la funcion cardiovascular. |
US6855727B2 (en) * | 2000-12-04 | 2005-02-15 | Yaizu Suisankagaku Industry Co., Ltd. | Muscular fatigue-controlling composition and method for providing muscular fatigue-controlling effect |
JP2002338473A (ja) * | 2001-05-15 | 2002-11-27 | Yaizu Suisankagaku Industry Co Ltd | 抗疲労組成物 |
US20030069203A1 (en) * | 2001-06-04 | 2003-04-10 | Lee Steve S. | Method for increasing human performance by reducing muscle fatigue and recovery time through oral administration of adenosine triphosphate |
US7629329B2 (en) * | 2001-06-04 | 2009-12-08 | Tsi Health Sciences, Inc. | Method for increasing muscle mass and strength through administration of adenosine triphosphate |
US20040147458A1 (en) * | 2002-03-28 | 2004-07-29 | Van Tassel Richard K | Compositions to reduce exercise-induced swelling of joints |
US20040127428A1 (en) * | 2002-12-28 | 2004-07-01 | Kenyon Keith E. | Use of D-ribose, including as a topical vehicle, to promote faster healing, including from surgical procedures |
US7494643B2 (en) * | 2003-07-22 | 2009-02-24 | Rendon Marta I | Method and topical composition for the treatment of hyperpigmented skin |
US20080089877A1 (en) * | 2003-08-14 | 2008-04-17 | Udell Ronald G | Super Absorption Coenzyme Q10 |
US8124072B2 (en) | 2003-09-29 | 2012-02-28 | Soft Gel Technologies, Inc. | Solubilized CoQ-10 |
WO2005032278A1 (en) | 2003-09-29 | 2005-04-14 | Soft Gel Technologies, Inc. | SOLUBILIZED CoQ-10 |
US7169385B2 (en) * | 2003-09-29 | 2007-01-30 | Ronald G. Udell | Solubilized CoQ-10 and carnitine |
AU2005216192B2 (en) * | 2004-02-23 | 2010-11-04 | Strategic Science & Technologies, Llc | Topical delivery of a nitric oxide donor to improve body and skin appearance |
JP4754484B2 (ja) * | 2004-03-18 | 2011-08-24 | 田辺三菱製薬株式会社 | うつ様症状改善剤 |
US20110028548A1 (en) * | 2004-04-19 | 2011-02-03 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
US9226909B2 (en) | 2004-04-19 | 2016-01-05 | Strategic Science & Technologies, Llc | Beneficial effects of increasing local blood flow |
WO2005102282A1 (en) | 2004-04-19 | 2005-11-03 | Strategic Science & Technologies, Llc | Transdermal delivery of beneficial substances effected by a hostile biophysical environment |
US20090105336A1 (en) * | 2004-04-19 | 2009-04-23 | Strategic Science & Technologies, Llc | Beneficial Effects of Increasing Local Blood Flow |
JP2005336176A (ja) * | 2004-04-28 | 2005-12-08 | Tanabe Seiyaku Co Ltd | 肉体疲労改善剤 |
EP3698780A1 (de) * | 2004-08-09 | 2020-08-26 | Enrique Melendez Hevia | Glycin als nahrungergänzungsmittel zur vorbeugung und/oder behandlung einer durch einen virus in einem der kollagen bedürfenden menschen collagensynthese bedarf verursachten infektionskrankheit |
US20060051435A1 (en) * | 2004-08-19 | 2006-03-09 | Udell Ronald G | Nutritional supplement for body fat reduction |
US20050249803A1 (en) * | 2005-06-03 | 2005-11-10 | Udell Ronald G | Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
US7887852B2 (en) * | 2005-06-03 | 2011-02-15 | Soft Gel Technologies, Inc. | Soft gel capsules containing polymethoxylated flavones and palm oil tocotrienols |
JP5220415B2 (ja) * | 2005-09-06 | 2013-06-26 | 株式会社明治 | 老人性貧血を防止又は治療するためのアミノ酸組成物 |
US20070104805A1 (en) * | 2005-11-01 | 2007-05-10 | Udell Ronald G | Compositions of Hoodia Gordonii and Pinolenic Acid Derivatives |
US20070178176A1 (en) * | 2006-02-02 | 2007-08-02 | Chithan Kandaswami | Composition and method for promoting weight loss |
US7989009B2 (en) * | 2006-02-02 | 2011-08-02 | Advocare International, L.P. | Composition and method for promoting weight loss |
JP5254227B2 (ja) * | 2006-07-17 | 2013-08-07 | クリスチャン ラインズ,トーマス | ケルセチン含有組成物 |
WO2008011364A2 (en) * | 2006-07-17 | 2008-01-24 | Thomas Christian Lines | Quercetin-containing compositions |
JP2009037201A (ja) * | 2007-03-14 | 2009-02-19 | Fujifilm Corp | 感光性樹脂組成物、それを用いた硬化レリーフパターンの製造方法及び半導体装置 |
US20080226696A1 (en) * | 2007-03-15 | 2008-09-18 | Ben Treadwell | Methods of improving learning abilities of aged companion animals |
US8343541B2 (en) | 2007-03-15 | 2013-01-01 | Soft Gel Technologies, Inc. | Ubiquinol and alpha lipoic acid compositions |
US20090061016A1 (en) * | 2007-09-05 | 2009-03-05 | Selzer Jonathan A | Seawater Based Dietary Supplement Product for Energy and Electrolyte Replacement |
JP5235439B2 (ja) * | 2008-02-06 | 2013-07-10 | 丸善製薬株式会社 | HMG−CoA還元酵素産生促進剤 |
US20090005320A1 (en) * | 2008-09-02 | 2009-01-01 | Bruce Kneller | Compositions comprising amino acid bicarbonate and methods of use thereof |
WO2010151241A1 (en) | 2009-06-24 | 2010-12-29 | Strategic Science & Technologies, Llc | Topical composition containing naproxen |
US11684624B2 (en) | 2009-06-24 | 2023-06-27 | Strategic Science & Technologies, Llc | Treatment of erectile dysfunction and other indications |
AU2009348470B2 (en) | 2009-06-24 | 2015-04-02 | Strategic Science & Technologies, Llc | Topical composition containing ibuprofen |
US8980542B2 (en) * | 2010-02-16 | 2015-03-17 | Viacell, Llc | Arginine-containing compositions and methods for treating red blood cells |
CN105878172A (zh) | 2010-12-29 | 2016-08-24 | 战略科学与技术有限责任公司 | 治疗变态反应和其它适应症的系统和方法 |
JP2014504592A (ja) | 2010-12-29 | 2014-02-24 | ストラテジック サイエンス アンド テクノロジーズ, エルエルシー | 勃起不全および他の適応症の処置 |
US11730760B2 (en) | 2011-04-01 | 2023-08-22 | The Bioregentech Institute, Inc. | Laser assisted wound healing protocol and system |
US11389663B2 (en) | 2011-04-01 | 2022-07-19 | Bioregentech, Inc. | Laser assisted wound healing protocol and system |
EP2859889A1 (de) * | 2013-10-14 | 2015-04-15 | Abbott Laboratories | Zusammensetzungen und Verfahren zur Verbesserung der kognitiven Funktion |
JP7082258B2 (ja) | 2016-02-01 | 2022-06-08 | バイオエナジー ライフ サイエンス,インコーポレイティド | うっ血性心不全に罹っている対象を治療するためのリボースの使用 |
WO2018089954A1 (en) | 2016-11-10 | 2018-05-17 | BioRegentech | Laser assisted wound healing protocol and system |
US11654293B2 (en) * | 2016-11-10 | 2023-05-23 | The Bioregentech Institute, Inc. | Laser assisted wound healing protocol and system |
CN111655072A (zh) * | 2018-01-25 | 2020-09-11 | 吴世仁 | 具有不同长度的牙刷毛的牙刷 |
BR112021010500A2 (pt) | 2018-11-30 | 2021-08-24 | Beth Israel Deaconess Medical Center, Inc. | Método para reduzir a p-selectina solúvel em um paciente com câncer, método para reduzir ou prevenir a formação de um trombo em um paciente com câncer, método para promover a regressão tumoral em um paciente com câncer, método para estabilizar ou reduzir o câncer metastático em um paciente com câncer, composição farmacêutica para reduzir a p-selectina solúvel em um paciente com câncer, composição farmacêutica para reduzir ou prevenir a formação de um trombo em um paciente com câncer, composição farmacêutica para promover a regressão tumoral em um paciente com câncer e composição farmacêutica para estabilizar ou reduzir câncer metastático em um paciente com câncer |
WO2023135827A1 (ja) * | 2022-01-13 | 2023-07-20 | NeSA合同会社 | 神経変性疾患の進行遅延及び防御剤 |
Family Cites Families (44)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US2417841A (en) * | 1944-06-21 | 1947-03-25 | Frances R Ruskin | Nucleotide compounds of components of vitamin b complex |
US2844514A (en) * | 1953-11-04 | 1958-07-22 | Pabst Brewing Co | Process for the production of nucleotides |
US3009859A (en) * | 1958-07-22 | 1961-11-21 | Laborit Henri | Potassium aspartate and magnesium aspartate fatigue-recovery promoting process and compositions |
US3104203A (en) * | 1959-12-09 | 1963-09-17 | Union Carbide Corp | Composition of matter containing procaine adenylate |
US3157635A (en) * | 1960-08-05 | 1964-11-17 | Takeda Chemical Industries Ltd | Sulfonic acid cation exchange resin purification of nucleotides |
DE1442304A1 (de) * | 1962-08-08 | 1970-01-15 | Takeda Chemical Industries Ltd | Verfahren zur Herstellung von Purinderivaten |
US3329567A (en) * | 1963-09-16 | 1967-07-04 | Union Carbide Corp | Synergistic effect of adenylic nucleotides in digitalis therapy |
US3686392A (en) * | 1965-01-27 | 1972-08-22 | Takeda Chemical Industries Ltd | Nutrient ration for increasing growth of livestock and poultry |
US3931402A (en) * | 1970-12-02 | 1976-01-06 | Societa Prodotti Antibiotici S.P.A. | Preparations containing hexoses |
FR2129833B1 (de) * | 1971-03-16 | 1974-08-02 | Cerm Cent Europ Rech Mauvernay | |
US3819830A (en) * | 1971-07-01 | 1974-06-25 | Dainippon Pharmaceutical Co | Method for treating diseases by coenzyme a and adenosine triphosphate and composition therefor |
US3978213A (en) * | 1972-07-10 | 1976-08-31 | Nelson Research & Development Company | Cosmetic use of cyclic amp and phosphodiesterase inhibitors |
ZA7468B (en) * | 1973-01-16 | 1974-11-27 | J Voorhees | Compositions and treatment of proliferatave skin diseases with phosphodiesterase inhibitors |
US4211770A (en) * | 1973-01-16 | 1980-07-08 | The Upjohn Company | Treatment of psoriasis intralesionally with N6 -2'-O-dibutyryl cyclic AMP |
US3988466A (en) * | 1973-06-01 | 1976-10-26 | Kyowa Hakko Kogyo Co., Ltd. | Prevention of gastric lesions |
DE2509531A1 (de) * | 1975-03-05 | 1976-09-16 | Thomae Gmbh Dr K | Antivirales mittel |
US4363818A (en) * | 1975-06-04 | 1982-12-14 | Gottlieb Sheldon K | Method for relief of burning, itching, and pain of cutaneous and mucosal surfaces |
US4126701A (en) * | 1975-10-24 | 1978-11-21 | A.H.P., Inc. | Process of sparing poultry from the effect of toxins |
US4078971A (en) * | 1976-03-31 | 1978-03-14 | Temple University | Bound, active cellular organelles and method of producing same |
US4207315A (en) * | 1976-10-20 | 1980-06-10 | University Patents, Inc. | Process for treating proliferative skin diseases using certain diamino compounds |
US4414202A (en) * | 1980-02-19 | 1983-11-08 | Silvetti Anthony N | Composition for treatment of wounds |
US4308257A (en) * | 1980-06-03 | 1981-12-29 | Saul Caspe | Accelerating cellular repair composition for the human body and method of administering same |
DE3026368A1 (de) * | 1980-07-11 | 1982-02-18 | Lentia GmbH Chem. u. pharm. Erzeugnisse - Industriebedarf, 8000 München | Naehrloesung fuer die vollstaendige parenterale ernaehrung und fuer gesteigerte energieproduktion |
US4546095A (en) * | 1980-07-21 | 1985-10-08 | Markov Angel K | Use of fructose-1,6-diphosphate for treating myocardial infarction |
FR2489145A1 (fr) * | 1980-09-04 | 1982-03-05 | Geistlich Soehne Ag | Compositions pharmaceutiques accelerant la guerison de blessures |
US4362745A (en) * | 1980-11-19 | 1982-12-07 | Johnston Frederick B | Medical process and preparation |
JPS58500526A (ja) * | 1981-04-17 | 1983-04-07 | アメリカン ホスピタル サプライ コ−ポレ−シヨン | 非経口栄養供給のための改良溶液 |
ATE20824T1 (de) * | 1981-06-25 | 1986-08-15 | Serapharm Gmbh & Co Kg | Angereichertes plasmaderivat zur unterstuetzung von wundverschluss und wundheilung. |
JPS58129970A (ja) * | 1982-01-26 | 1983-08-03 | Kazutomo Imahori | アデノシン三リン酸変換用装置 |
CA1237670A (en) * | 1983-05-26 | 1988-06-07 | Andrew S. Janoff | Drug preparations of reduced toxicity |
US4575498A (en) * | 1983-07-21 | 1986-03-11 | Duke University | Method for restoring depleted purine nucleotide pools |
FR2556594B1 (fr) * | 1983-12-20 | 1988-09-09 | Synthelabo | Solutions d'acides amines |
US4767785A (en) * | 1984-01-18 | 1988-08-30 | Michael Georgieff | Hypocaloric preparation and intravenous method for hypocaloric treatment of patients |
EP0150053B1 (de) * | 1984-01-18 | 1990-06-13 | Oehmke, Martin, Dr. | Niedrig osmotisches hypokalorisches wässriges Präparat für die Infusion |
US4604286A (en) * | 1984-09-17 | 1986-08-05 | Daigo Nutritive Chemicals, Ltd. | Infusion solution for parenteral nutrition |
US4605644A (en) * | 1985-02-07 | 1986-08-12 | Regents Of The University Of Minnesota | Method for stimulating recovery from ischemia employing ribose and adenine |
US4764375A (en) * | 1985-09-11 | 1988-08-16 | Kv Pharmaceutical Company | Sachet drug delivery system |
US4772591A (en) * | 1985-09-25 | 1988-09-20 | Peritain, Ltd. | Method for accelerated wound healing |
DE3684564D1 (de) * | 1985-11-18 | 1992-04-30 | Beecham Group Plc | Veterinaere zusammensetzungen. |
US4923851A (en) * | 1987-12-29 | 1990-05-08 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
US4871718A (en) * | 1987-12-29 | 1989-10-03 | Raymond A. Roncari | Composition of matter for increasing intracellular ATP levels and physical performance levels and for increasing the rate of wound repair |
US4945087A (en) * | 1988-03-31 | 1990-07-31 | Warner-Lambert Company | Taste masking of thymol |
US4916161A (en) * | 1988-10-25 | 1990-04-10 | Bristol-Myers Squibb | Taste-masking pharmaceutical agents |
US4983394A (en) * | 1990-05-03 | 1991-01-08 | Warner-Lambert Company | Flavor enhancing and medicinal taste masking agent |
-
1987
- 1987-12-29 US US07/139,288 patent/US4871718A/en not_active Expired - Lifetime
-
1988
- 1988-06-15 AU AU17690/88A patent/AU600139B2/en not_active Ceased
- 1988-06-20 NZ NZ225106A patent/NZ225106A/xx unknown
- 1988-06-23 CA CA000570187A patent/CA1325593C/en not_active Expired - Fee Related
- 1988-07-28 JP JP63187078A patent/JPH01175939A/ja active Granted
- 1988-08-24 IE IE258388A patent/IE62263B1/en not_active IP Right Cessation
- 1988-10-19 DE DE8888309826T patent/DE3872372T2/de not_active Expired - Lifetime
- 1988-10-19 AT AT88309826T patent/ATE77557T1/de not_active IP Right Cessation
- 1988-10-19 ES ES88309826T patent/ES2045141T3/es not_active Expired - Lifetime
- 1988-10-19 DE DE198888309826T patent/DE324227T1/de active Pending
- 1988-10-19 EP EP88309826A patent/EP0324227B1/de not_active Expired - Lifetime
- 1988-12-28 DK DK726088A patent/DK726088A/da not_active Application Discontinuation
-
1989
- 1989-10-02 US US07/416,248 patent/US5391550A/en not_active Expired - Fee Related
-
1991
- 1991-06-07 GR GR90300016T patent/GR900300016T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
AU600139B2 (en) | 1990-08-02 |
AU1769088A (en) | 1989-06-29 |
JPH01175939A (ja) | 1989-07-12 |
DE3872372D1 (de) | 1992-07-30 |
DK726088A (da) | 1989-06-30 |
CA1325593C (en) | 1993-12-28 |
IE882583L (en) | 1989-06-29 |
IE62263B1 (en) | 1995-01-11 |
DK726088D0 (da) | 1988-12-28 |
ES2045141T3 (es) | 1994-01-16 |
EP0324227A1 (de) | 1989-07-19 |
EP0324227B1 (de) | 1992-06-24 |
NZ225106A (en) | 1990-10-26 |
JPH0520414B2 (de) | 1993-03-19 |
GR900300016T1 (en) | 1991-06-07 |
US5391550A (en) | 1995-02-21 |
DE3872372T2 (de) | 1992-12-10 |
US4871718A (en) | 1989-10-03 |
DE324227T1 (de) | 1989-11-16 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE77557T1 (de) | Zusammensetzung zur erhoehung der intrazell-atpspiegel und des physischen leistungsniveaus und zur erhoehung der geschwindigkeit von wundenheilung. | |
DE3785684T2 (de) | Pyrrolidinamid-Derivate von Acylaminosäure, pharmazeutische Zusammensetzung und Verwendung. | |
DE3752112T2 (de) | Verwendung von Inositoltriphosphat zur Behandlung von Entzündungen | |
DE68923819T2 (de) | Verwendung von gamma-Hydroxy-Buttersäuresalzen zur Herstellung von pharmazeutischen Zusammensetzungen zur Verwendung bei der Behandlung von Alkoholismus und die hergestellten Zusammensetzungen. | |
ATE83659T1 (de) | Verwendung von indolon-derivaten zur herstellung von arzneimitteln zur behandlung des parkinsonismus. | |
DE59010810D1 (de) | Arzneimittel enthaltend als Wirkstoff R-alpha-Liponsäure oder S-alpha-Liponsäure | |
KR910000158A (ko) | 의약용 화합물 및 그것의 사용방법 | |
NO874892D0 (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive 3-(omega-(3,5-di-t-butyl-4-hydroxyfenyl)-alkanoyl)-pyrroler og deres deoxy-analoger. | |
DE69133077D1 (de) | Herstellung von ST1435 enthaltenden pharmazeutischen Zusammensetzungen zur topischen Verwendung | |
PT95212A (pt) | Processo para a preparacao de uma composicao para uso topico para o tratamento da fragilidade capilar, contendo defibrotide | |
ES2059588T3 (es) | Factor xiii para la prevencion de una hemorragia intraventricular. | |
ES2059457T3 (es) | Utilizacion de bezafibrato para el tratamiento de la diabetes. | |
NO881768L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,3-dioksaner. | |
IE46171L (en) | N-pyrrolidinylmethylbenzamide derivative. | |
DK166343C (da) | Forbedret piroxicamholdigt laegemiddel | |
NO883986L (no) | Fremgangsmaate for fremstilling av n-(substituert alkyliden)-1,2,3,4-tetrahydro-9-akridinaminer og anvendelse derav som medikamenter. | |
IE44034L (en) | Pyrrolidone carboxylic acids. | |
ATE58521T1 (de) | Lysinsalz der 4-biphenylessigsaeure und es enthaltende augenheilmittel. | |
DE319316T1 (de) | Monoester von griseolsaeure, ihre herstellung und verwendung. | |
NO852741L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater | |
ATE4023T1 (de) | Biflavanon enthaltende arzneimittel. | |
NO880639D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive oksimetere av 2,6-dioksabicyklo (3, 3, 0)oktanoner. | |
NO883987D0 (no) | Fremgangsmaate for fremstilling av n-(substituert aklyliden) kondensert bicykloalkyliden og anvendelse derav som medikamenter. | |
NO863005D0 (no) | Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater. | |
NO164539C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktivt 5-nafthyl-2,4-dimethyl-3h-1,2,4-triazol-3-thion. |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification | ||
REN | Ceased due to non-payment of the annual fee |